Neuberger Berman Income Funds - Neuberger High Yield Strategies Fund Inc. (NHS)

NHS Income Statement

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Operating Revenue	-	-	-	-0	-
Other Revenue	23.28	22.8	22.35	17.66	16.32
Revenue	23.28	22.8	22.35	17.66	16.32
Revenue Growth (YoY)	2.12%	2.01%	26.56%	8.20%	-24.20%
Gross Profit	23.28	22.8	22.35	17.66	16.32
Selling, General & Admin	2.69	2.77	2.55	2.25	2.63
Operating Expenses	2.69	2.77	2.55	2.25	2.63
Operating Income	20.59	20.03	19.8	15.42	13.69
Interest Expense	-5.2	-6.03	-8.46	-2	-2.1
Other Non Operating Income (Expenses)	-	-	-	-	-0
EBT Excluding Unusual Items	15.39	14	11.34	13.41	11.59
Gain (Loss) on Sale of Investments	4.83	23.94	-7.62	-46.9	15.21
Pretax Income	20.22	37.94	3.72	-33.49	26.8
Net Income	20.22	37.94	3.72	-33.49	26.8
Net Income to Common	20.22	37.94	3.72	-33.49	26.8
Net Income Growth	-46.72%	920.57%	-	-	786.80%
Shares Outstanding (Basic)	31	30	26	19	15
Shares Outstanding (Diluted)	31	30	26	19	15
Shares Change (YoY)	5.38%	14.73%	33.43%	32.52%	-24.96%
EPS (Basic)	0.64	1.28	0.14	-1.72	1.83
EPS (Diluted)	0.64	1.28	0.14	-1.72	1.83
EPS Growth	-49.44%	789.54%	-	-	1081.74%
Dividend Per Share	1.086	1.086	1.086	1.086	1.086
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	88.43%	87.85%	88.60%	87.28%	83.89%
Profit Margin	86.82%	166.39%	16.63%	-189.61%	164.18%
EBIT	20.59	20.03	19.8	15.42	13.69
EBIT Margin	88.43%	87.85%	88.60%	87.28%	83.89%
Revenue as Reported	23.28	-	-	17.66	16.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q